Infectious Diseases

Medicago announced Tuesday that its two-dose vaccine was 71% effective at preventing COVID-19 infection in a large, late-stage study that included several variants including the delta variant.

Study of 6-million vaccinated individuals looked at 23 possible serious outcomes.

Even though some of the genetic changes in the new variant appear worrying, it's still unclear if the virus will pose a significant public health threat.

The Food and Drug Administration posted its analysis of the pill ahead of a public meeting next week where academic and other experts will weigh in on its safety and effectiveness. The agency isn't required to follow the group's advice.

GSK continues to work with provinces and territories to make sotrovimab available to appropriate patients.

Patients in the new study used the a tool sent photographs of their surgical wounds three, seven and 15 days after surgery.

Common side effects of zoster vaccine may be mistakenly attributed to the influenza vaccine.

Study finds a 64% relative reduction in the risk for death, and one life saved for every 400 patients enrolled in the remote monitoring service.